歡迎光臨源葉生物,登錄 | 注冊 |
當(dāng)前位置: 首頁 > 小分子抑制劑 > CytoskeletalSignaling > CCT251545

瀏覽歷史

S83824

CCT251545

MedMol 98%
  • 英文名:
  • CCT251545
  • 別名:
  • CAS號:
  • 1661839-45-7
  • 分子式:
  • C23H24ClN5O
  • 分子量:
  • 421.9225
  • 核磁/質(zhì)譜:
品牌貨號產(chǎn)品規(guī)格價格(RMB) 庫存(上海) 北京 武漢 南京 數(shù)量計量單位 加入購物車...
MedMol S83824-2mg 98% ¥470.00元 5 - - - EA 加入購物車
MedMol S83824-5mg 98% ¥860.00元 6 - - - EA 加入購物車
MedMol S83824-10mg 98% ¥1700.00元 5 - - - EA 加入購物車
MedMol S83824-50mg 98% ¥5168.00元 2 - - - EA 加入購物車
源葉(MedMol) S83824-100mg 98% ¥7900.00元 預(yù)計交期:2-3天 - - - EA 加入購物車
大包裝詢價

提交您的電話號碼并同意《個人信息授權(quán)與保護(hù)申明》,到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻(xiàn)

質(zhì)檢證書(COA)

摩爾濃度計算器

相關(guān)產(chǎn)品

  • 提示:詳情請下載說明書。
  • 產(chǎn)品描述: CCT251545 是一種有效的口服生物利用型的 WNT 信號抑制劑,在7dF3細(xì)胞中的IC50值為5 nM。CCT251545 還可作為選擇性化學(xué)探針,探討 CDK8 和 CDK19 在人類疾病中的作用
  • 靶點: CDK8; CDK19; Wnt(in 7dF3 cells):5 nM;Wnt/beta-catenin
  • 體外研究:
    The suppression of the WNT pathway activity by CCT251545 is not unique to a specific cell line, is independent of exogenous WNT pathway stimulation, does not result from destabilization of TCF1 or TCF4, and is not due to interference with the luciferase-based reporter readout. CCT251545 also demonstrates a lack of transporter-mediated efflux and a lack of activity across broad in vitro panels of enzyme, receptor, and ion channel targets
  • 體內(nèi)研究:
    CCT251545 is a potent small-molecule inhibitor of WNT signaling with good oral pharmacokinetics. We demonstrate inhibition of WNT pathway activity in a solid human tumor xenograft model with evidence for tumor growth inhibition following oral dosing
  • 細(xì)胞實驗: Cell lines: 7dF3 cells, HEK293 cells, SW480, LS174T, COLO205 human colorectal cancer cells Concentrations: 9.1 μM - 0.068 nM Incubation Time: 2 h, 6 h Method: Taqman Assays. 7dF3 cells are seeded at 20 000 cells/well into 96-well cell culture plates. After overnight incubation the cells are treated with CCT251545 at concentrations ranging from 9.1 μM to 0.068 nM. After 2 or 6 h of incubation, cells are washed with PBS and stored at ?80 ℃. Cells are lysed in Cells-to-cDNA II Cell lysis buffer and transferred to PCR plates.
  • 動物實驗: Animal Models: Female NMRI mice, Male Wistar rats Dosages: 0.2 mg/kg, 0.5 mg/kg Administration: IV, Oral gavage
  • 參考文獻(xiàn):
    1. Aurélie Mallinger, et al. Discovery of potent, orally bioavailable, small-molecule inhibitors of WNT signaling from a cell-based pathway screen. J Med Chem. 2015 Feb 26;58(4):1717-35. 2. Trevor Dale, et al. A selective chemical probe for exploring the role of CDK8 and CDK19 in human disease. Nat Chem Biol. 2015 Dec;11(12):973-980.
  • 溶解性: Soluble  in  DMSO、Ethanol
  • 保存條件: -20℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 2.37 ml 11.851 ml 23.701 ml
    5 mM 0.474 ml 2.37 ml 4.74 ml
    10 mM 0.237 ml 1.185 ml 2.37 ml
    50 mM 0.047 ml 0.237 ml 0.474 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號:

本計算器可幫助您計算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:


質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產(chǎn)品僅用作科學(xué)研究,銷售產(chǎn)品行為均適用于我司網(wǎng)上所列通用銷售條款。